RevCycle Intelligence December 19, 2017
Eleven medical societies called on policymakers to prevent CMS from applying MIPS adjustments to Part B drug reimbursements and limiting patient access to drug treatments.
– Applying Merit-Based Incentive Payment System (MIPS) adjustments to Medicare Part B drug payments will restrict patient access to critical treatments, 11 medical societies recently told congressional leaders.
The medical societies, including the American College of Rheumatology, American Society of Clinical Oncology, and American Urological Association, urged Congress to abandon a new policy detailed in the final 2018 MACRA implementation rule that will apply MIPS payment adjustments to Part B drug payments in addition to fee schedule services reimbursements starting in 2018.
“If left as is, this policy will negatively impact patients’ access to critical...
Today's Sponsors
Today's Sponsor